154 related articles for article (PubMed ID: 7698151)
21. Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma.
Daghighian F; Pentlow KS; Larson SM; Graham MC; DiResta GR; Yeh SD; Macapinlac H; Finn RD; Arbit E; Cheung NK
Eur J Nucl Med; 1993 May; 20(5):402-9. PubMed ID: 8519259
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer.
Russell PJ; Plomley J; Shon IH; O'Grady H; Pearce N
Cell Biophys; 1993; 22(1-3):27-47. PubMed ID: 7889541
[TBL] [Abstract][Full Text] [Related]
23. Production and characterisation of a C595 antibody-99mTc conjugate for immunoscintigraphy of bladder cancer.
Simms MS; Murray A; Denton G; Scholfield DP; Price MR; Perkins AC; Bishop MC
Urol Res; 2001 Feb; 29(1):13-9. PubMed ID: 11310209
[TBL] [Abstract][Full Text] [Related]
24. Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.
Murray A; Simms MS; Scholfield DP; Vincent RM; Denton G; Bishop MC; Price MR; Perkins AC
J Nucl Med; 2001 May; 42(5):726-32. PubMed ID: 11337567
[TBL] [Abstract][Full Text] [Related]
25. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
[TBL] [Abstract][Full Text] [Related]
26. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
28. Human milk fat globule antigen 1 (HMFG1) expression in prostatic carcinoma and immunotargeting with a radiolabelled monoclonal anti-HMFG1 antibody.
Ljung G; Lennernäs B; Nordgren H; Holmberg A; Westlin JE; Nilsson S; Edgren M
Anticancer Res; 2000; 20(4):2321-4. PubMed ID: 10953291
[TBL] [Abstract][Full Text] [Related]
29. Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors.
Arbit E; Cheung NK; Yeh SD; Daghighian F; Zhang JJ; Cordon-Cardo C; Pentlow K; Canete A; Finn R; Larson SM
Eur J Nucl Med; 1995 May; 22(5):419-26. PubMed ID: 7641750
[TBL] [Abstract][Full Text] [Related]
30. Immunotargeting with monoclonal cytokeratin 8 antibodies of human urothelial cancer transplanted to nude mice.
Letocha H; Nilsson S; Silén A; Ekblom J; Arnberg H; Wiklund B; Westlin JE
Acta Oncol; 1993; 32(7-8):793-800. PubMed ID: 7508236
[TBL] [Abstract][Full Text] [Related]
31. Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas.
Baum RP; Niesen A; Hertel A; Adams S; Kojouharoff G; Goldenberg DM; Hör G
Cancer; 1994 Feb; 73(3 Suppl):896-9. PubMed ID: 8306276
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
[TBL] [Abstract][Full Text] [Related]
33. Detection of transitional cell carcinoma in bladder by intravesical injection of monoclonal antibodies.
Chopin DK; deKernion JB
Urol Res; 1986; 14(3):145-8. PubMed ID: 3529570
[TBL] [Abstract][Full Text] [Related]
34. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report.
Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K
Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532
[TBL] [Abstract][Full Text] [Related]
35. A novel anti-seminoma monoclonal antibody (M2A) labelled with technetium-99m: potential application for radioimmunoscintigraphy.
Marks A; Ballinger JR; Reilly RM; Law J; Baumal R
Br J Urol; 1995 Feb; 75(2):225-9. PubMed ID: 7850331
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodies.
Gooden CS; Snook DE; Epenetos AA
Cell Biophys; 1993; 22(1-3):49-59. PubMed ID: 7889542
[TBL] [Abstract][Full Text] [Related]
37. Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. A model for intravesical radioimmunotherapy.
Russell PJ; Ho Shon I; Boniface GR; Izard ME; Philips J; Raghavan D; Walker KZ
Urol Res; 1991; 19(4):207-13. PubMed ID: 1926654
[TBL] [Abstract][Full Text] [Related]
38. Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.
Ind TE; Granowska M; Britton KE; Morris G; Lowe DG; Hudson CN; Shepherd JH
Br J Cancer; 1994 Dec; 70(6):1263-6. PubMed ID: 7981086
[TBL] [Abstract][Full Text] [Related]
39. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunoimaging diagnosis of human bladder carcinoma.
Yu LZ; Gu FL; Zhang CL
Scand J Urol Nephrol Suppl; 1994; 157():13-7. PubMed ID: 7939444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
